In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Merkel Cell Carcinoma
Related studies linked through entity extraction aliases.
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1
- Status
- COMPLETED
- Phase
- PHASE2
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
LITT and Pembrolizumab in Recurrent Brain Metastasis
- Status
- TERMINATED
- Phase
- PHASE1
Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE3
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
- Status
- TERMINATED
- Phase
- N/A
A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
- Status
- RECRUITING
- Phase
- PHASE2
High-Risk Skin Cancers With Atezolizumab Plus NT-I7
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy
- Status
- TERMINATED
- Phase
- PHASE2